Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 30 June, 2021
Baseline Eval Before Tx:<sup>1-4</sup>
By
vgreene
, 30 June, 2021
Baseline Eval Before Tx
By
vgreene
, 30 June, 2021
Monitoring After Tx:<sup>1-3</sup>
By
vgreene
, 30 June, 2021
Monitoring After tx
By
vgreene
, 30 June, 2021
Monitoring During Tx:<sup>1-3</sup>
By
vgreene
, 30 June, 2021
Monitoring During Tx
By
vgreene
, 30 June, 2021
Baseline Eval Before Tx:<sup>1-3</sup>
By
vgreene
, 30 June, 2021
Baseline Eval Before Tx
By
vgreene
, 29 June, 2021
mitoxantrone
By
vgreene
, 29 June, 2021
daunorubicin
Pagination
First page
Previous page
…
Page
1032
Page
1033
Page
1034
Page
1035
Current page
1036
Page
1037
Page
1038
Page
1039
Page
1040
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube
